13,000 square-meters space for Life Science business sector accommodates 11,000 pallet positions and more than 50,000 stock-keeping units

Merck, a leading science and technology company, will open a new, € 20 million distribution center in Cajamar, São Paulo, Brazil to better serve its Life Science customers in the region. The new space, which will be operational in late February, has an area of 13,000 square meters – twice as large as the former location in Cotia.

According to Vinícius Andremarchi, Head of Distribution for Life Science at Merck, in Brazil, the move to a larger facility supports the country's growing demand for life science products. The outskirts of São Paulo, including the capital, account for 60% of the Life Science customer demand in Brazil. The new space allows for faster deliveries in the region, in some cases, taking less than 24 hours.

"In 2023, the pharmaceutical industry and academic markets in Brazil grew by 10.5%. With that comes the demand for products and solutions offered by our Life Science business sector. The new distribution center allows us to store a more robust portfolio in an appropriate and accessible way,” said Andremarchi.

The layout of the new space makes it possible to optimize workflows and has more technological equipment and automated, ergonomic workstations for employees. Other features include a 1,000m² mezzanine, laboratories, administrative rooms, employee amenities and customer reception.

The new site is closely alignment with Merck's global sustainability objectives: With a well-designed environment, the space has received the Leadership in Energy and Environmental Design (LEED) Gold level certification from the Green Building Council (GBC), the world's largest non-profit organization that steers the construction market towards more sustainable practices.

About Merck

Merck, a leading science and technology company, operates across life science, healthcare and electronics. More than 64,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2022, Merck generated sales of € 22.2 billion in 66 countries.

Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as MilliporeSigma in life science, EMD Serono in healthcare, and EMD Electronics in electronics.

Recent news from Merck